JW Asset Management LLC Cuts Stake in Establishment Labs Holdings Inc. $ESTA

JW Asset Management LLC trimmed its position in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 0.3% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 3,082,785 shares of the company’s stock after selling 9,700 shares during the quarter. Establishment Labs comprises approximately 60.6% of JW Asset Management LLC’s portfolio, making the stock its largest holding. JW Asset Management LLC owned 0.11% of Establishment Labs worth $126,363,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Establishment Labs by 20.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 57,215 shares of the company’s stock valued at $2,335,000 after acquiring an additional 9,557 shares during the period. CWM LLC lifted its holdings in shares of Establishment Labs by 45.9% in the 2nd quarter. CWM LLC now owns 2,182 shares of the company’s stock worth $93,000 after purchasing an additional 686 shares in the last quarter. Pier Capital LLC bought a new position in shares of Establishment Labs in the 2nd quarter worth $10,777,000. Milestone Asset Management LLC acquired a new stake in Establishment Labs in the 2nd quarter valued at $523,000. Finally, Tyro Capital Management LLC increased its stake in Establishment Labs by 0.3% during the 2nd quarter. Tyro Capital Management LLC now owns 1,066,721 shares of the company’s stock valued at $45,560,000 after purchasing an additional 2,835 shares in the last quarter. Institutional investors own 72.91% of the company’s stock.

Establishment Labs Trading Up 2.5%

Shares of Establishment Labs stock opened at $76.23 on Thursday. The firm has a market cap of $2.22 billion, a PE ratio of -26.84 and a beta of 0.99. Establishment Labs Holdings Inc. has a 1 year low of $26.56 and a 1 year high of $78.24. The company has a debt-to-equity ratio of 15.06, a current ratio of 3.33 and a quick ratio of 2.10. The stock has a fifty day moving average price of $70.69 and a 200-day moving average price of $56.57.

Wall Street Analysts Forecast Growth

ESTA has been the subject of several recent research reports. JPMorgan Chase & Co. boosted their target price on shares of Establishment Labs from $71.00 to $80.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 17th. Needham & Company LLC reissued a “buy” rating and issued a $84.00 price objective on shares of Establishment Labs in a research note on Monday, January 12th. Citigroup lifted their target price on Establishment Labs from $62.00 to $75.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Canaccord Genuity Group lifted their price objective on shares of Establishment Labs from $72.00 to $85.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. Finally, Mizuho upped their target price on shares of Establishment Labs from $85.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Six research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $78.86.

About Establishment Labs

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.